NEW YORK (AP) — A new, higher-dose nasal spray for reversing opioid overdoses did not save more lives than the previous standard dose, but it did cause more vomiting and other side effects, researchers wrote in a study published Thursday. Three troops in eastern New York were given 8-milligram sprays. The study results were based on 354 instances in which troopers administered naloxone sprays from late March 2022 to mid-August 2023. But so too did those treated with the 8-milligram sprays, who got 1.58 doses, or 12.6 milligrams, on average. But other problems were significantly more common in the patients who got the higher-dose sprays.

---

Persons: —, Michael Dailey, Dailey Organizations: Centers for Disease Control, Albany Medical College, New York State Police, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: New York, Albany